United States

Back to map

Showing 21-30 of 345 grants

Title Institution Researcher Program Duration Total Award Amount
Nano-encapsulated microparticulate drug delivery platforms for decreasing islet graft immunogenicity University of Miami Dhanashree Surve Cures 01-March-2026 to 28-February-2029 $274.010,00
Optimizing Approaches to Type 1 Diabetes Prediction and Intervention in the Adult Autoantibody Positive Population Trustees of Indiana University Emily Sims Cures 01-February-2026 to 31-January-2029 $691.694,00
ACTin1 for DD: Developing and Testing a Digital Single Session Acceptance and Commitment Therapy Intervention for Type 1 Diabetes Distress Duke University Max Roberts Improving Lives 01-April-2026 to 31-March-2029 $241.710,00
Engineering Treg Signaling to Develop an Effective Cell Therapy for Type 1 Diabetes The Regents of the University of California, San Francisco Roberto Castro-Gutierrez Cures 01-March-2026 to 28-February-2029 $285.000,00
Rewiring Cellular Microenvironments with Synthetic Circuits for Subcutaneous Islet Transplantation Georgia Tech Research Corporation Alexander Vlahos Cures 01-March-2026 to 28-February-2031 $992.325,06
Protective Interventions against Loss of Function and Destruction of β cells in Type 1 Diabetes. Icahn School of Medicine at Mount Sinai Romina Bevacqua Cures 01-March-2026 to 28-February-2031 $999.999,00
Optimized bone marrow conditioning and tolerance assays to advance cell-based therapies for diabetes Stanford University Stephan Ramos Cures 01-March-2026 to 28-February-2029 $285.000,00
Targeting the Autoimmune Germinal Center Axis in Type 1 Diabetes Vanderbilt University Medical Center (VUMC) Rachel Bonami Cures 01-March-2026 to 29-February-2028 $600.000,00
Chemical Perturb-seq to identify small molecules controlling the maturation and survival on human beta cells Weill Medical College of Cornell University Xiaoshan Zhang Cures 01-March-2026 to 28-February-2029 $256.285,00
β Cell Mitochondrial Health as a Driver and Indicator of Immune Activation in Type 1 Diabetes Trustees of Indiana University Carmella Evans-Molina Cures 01-March-2026 to 28-February-2029 $748.179,00